Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Bronchiectasis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... of Diseases, Tenth Edition (ICD-10), is defined by damage to the bronchi, causing abnormal dilation and scarring. The airways become inflamed with thick mucus that is difficult to clear, which build-up creates an environment for ... Read More
-
Schizophrenia Epidemiology Analysis and Forecast, 2021-2031
... and economically catastrophic medical disorders. The disorder is characterized by the presence of both positive and negative symptoms. Positive symptoms tend to be psychotic and include hallucinations and delusions. Negative symptoms often occur years before ... Read More
-
Cytomegalovirus (HHV-5) Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Cytomegalovirus (HHV-5) Infections Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Arteriosclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Arteriosclerosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Arteriosclerosis. Report includes ... Read More
-
Human Papillomavirus Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Human Papillomavirus Infections Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Insomnia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Insomnia Clinical trials scenario. This report provides top line data relating to the clinical trials on Insomnia. Report includes ... Read More
-
Chronic Myelomonocytic Leukemia (CMML) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Chronic Myelomonocytic Leukemia (CMML) Clinical trials scenario. This report provides top line data ... Read More
-
Lennox-Gastaut Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Lennox-Gastaut Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Nasopharyngeal Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Nasopharyngeal Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Vasculitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 855,000 diagnosed prevalence cases of vasculitis across 16 pharmaceutical markets. There are five monoclonal antibody therapies approved for the treatment of various types of vasculitis. The vasculitis pipeline consists of 54 pharmaceuticals spanning all ... Read More
-
Taiwan Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
... Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Taiwan. It identifies the key trends in the country’s healthcare market and provides insights into ... Read More
-
IDC Perspective: How Technology Is Driving Diversity and Equity in Clinical Trials
... pharma is using to address these challenges and scans the evolving technology landscape that is playing a critical role in driving change. It also examines regulatory policies and guidances, identifies the key measures of success, ... Read More
-
United States Anticoagulation Therapy Market, By Product Type (Drugs (Novel Oral Anticoagulants (NOAC’s), Warfarin (VKA)), (PT/INR Testing Devices (In-Office Testing Devices, Analyzers, Reagents and Kits, Home Testing Devices), Service (Testing Services and Consulting Services), By Clinic (Hospital Associated Clinic, Independent Clinics, and Pharmacy-Based Clinics) Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Clinic (Hospital Associated Clinic, Independent Clinics, and Pharmacy-Based Clinics) Trend Analysis, Competitive Market Share & Forecast, 2018-2028 US Anticoagulation Therapy Market to Grow at a CAGR of 7.9% until 2028 United States Anticoagulation Therapy Market ... Read More
-
Global Clinical Trial Outsourcing Market 2022-2028
... Gen Consulting Company, the global clinical trial outsourcing market is poised to grow by USD 17 billion during 2022-2028, progressing at a CAGR of 6.1% during the forecast period. The report provides in-depth analysis and ... Read More
-
Medical Terminology Software Market by Application (Data Aggregation, Reimbursement, Data Integration, Clinical Trials), Products & Services (Services, Platforms), End User (Healthcare Providers, Healthcare Payers, IT Vendors) - Global Forecast to 2027
... software market is projected to reach USD 2.5 billion by 2027 from an estimated USD 1.0 billion in 2022, at a CAGR of 19.3% during the forecast period. Growth in this market is driven by ... Read More
-
COVID-19 Clinical Trials Market Intelligence Report - Global Forecast to 2027
... 14.03% during the forecast period. Market Statistics: The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when ... Read More
-
Clinical Trials Market Intelligence Report - Global Forecast to 2027
... the forecast period. Market Statistics: The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange ... Read More
-
Clinical Trial Supply & Logistics for Pharmaceutical Market Intelligence Report - Global Forecast to 2027
... USD 19,607.86 million in 2021, at a CAGR 7.69% during the forecast period. Market Statistics: The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. ... Read More
-
Pharmacovigilance Market Intelligence Report - Global Forecast to 2027
... period. Market Statistics: The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is ... Read More
-
2022 What’s Next for Pharma Innovation? - Emerging Technologies, Pipeline and Clinical Trials Review, Competitive SWOT Analysis, Partnering Deals
... and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to the leading competitors. The series includes current assessments of more than 1,000 companies worldwide. Depending on the company’s business nature ... Read More
-
2022 What’s Next for Biotechnology Innovation? - Emerging Technologies, Pipeline and Clinical Trials Review, Competitive SWOT Analysis, Partnering Deals
... budget. The series includes current assessments of more than 1,000 companies worldwide. Depending on the company’s business nature and structure, the assessments include all or some of the following analyses: Organization and Management, Acquisitions and ... Read More
-
Clinical Trial Supplies Market Intelligence Report - Global Forecast to 2027
... 7.69% during the forecast period. Market Statistics: The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when ... Read More
-
Narcolepsy Therapeutics Market - A Global and Country Level Analysis: Focus on Therapeutics, Indication, Product, and Country - Analysis and Forecast, 2022-2032
... to reach $4,912.3 million by 2032 from $915.2 million in 2021 at a CAGR of 15.93% during the forecast period 2022-2032. This The market is driven by certain factors, such as low satisfaction with available ... Read More
-
Orphan Drugs: Pharma/DTC genetic testing partnerships
... can inform clinical development programs. Partnership with genetic testing companies is key, but what are the pros, cons and dangers of operating in this unregulated space? In this report, experts in the field examine the ... Read More
-
Viral Vector Manufacturing Market Forecasts to 2028 – Global Analysis By Type (Pox Virus, Cytomegalovirus, Herpes Simplex Virus Vectors, Adenoviral Vectors), Application (Gene Therapy, Vaccinology) and By Geography
... Vector Manufacturing Market is accounted for $668.48 million in 2022 and is expected to reach $1,804.59 million by 2028 growing at a CAGR of 18.0% during the forecast period. Viral vectors are manufactured for delivering ... Read More
Research Assistance
